Literature DB >> 28631177

TRAIL in CD8+ T cells from patients with severe aplastic anemia.

Chunyan Liu1, Mengying Zheng1, Tian Zhang1, Rong Fu1, Huaquan Wang1, Ting Wang1, Weiwei Qi1, Zonghong Shao2,3.   

Abstract

Severe aplastic anemia (SAA) is an autoimmune disease caused mainly by activated T lymphocytes. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a member of TNF family, which can induce apoptosis and play a significant role in the pathogenesis of many autoimmune disorders. In this study, we sought to investigate the role of TRAIL in peripheral CD8+ T cells (CTLs) from SAA patients to clarify the autoimmune mechanisms of bone marrow failure in SAA. The expression of TRAIL and TRAIL-R2 in CTLs from SAA patients and normal controls were determined by flow cytometry, real-time PCR, and western blot. Expression of perforin and granzyme B and apoptosis in CTLs were evaluated by flow cytometry. The expression of TRAIL and TRAIL-R2 in SAA patients was significantly decreased compared with controls; however, there was no statistical difference in TRAIL mRNA expression between the two groups. TRAIL expression in CTLs was negatively correlated with the expression of perforin and granzyme B, and negatively correlated with CTLs apoptosis in SAA patients. The TRAIL pathway may be responsible for abnormal CTL activation in SAA patients. Further study of TRAIL and its receptors may elucidate the pathogenesis of SAA.

Entities:  

Keywords:  CTL; Severe aplastic anemia; TRAIL

Mesh:

Substances:

Year:  2017        PMID: 28631177     DOI: 10.1007/s12185-017-2279-0

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  25 in total

Review 1.  The diagnosis and treatment of aplastic anemia: a review.

Authors:  Maurizio Miano; Carlo Dufour
Journal:  Int J Hematol       Date:  2015-04-03       Impact factor: 2.490

2.  Cytokine gene polymorphisms in acquired bone marrow failure.

Authors:  Vinod Gidvani; Shakti Ramkissoon; Elaine M Sloand; Neal S Young
Journal:  Am J Hematol       Date:  2007-08       Impact factor: 10.047

Review 3.  [Aplastic anemia].

Authors:  H Schrezenmeier; S Körper; B Höchsmann
Journal:  Dtsch Med Wochenschr       Date:  2014-11-25       Impact factor: 0.628

Review 4.  [Acquired aplastic anemia].

Authors:  Hirohito Yamazaki
Journal:  Rinsho Ketsueki       Date:  2016-02

5.  Circulating myeloid dendritic cells are increased in individuals with severe aplastic anemia.

Authors:  Shao Zonghong; Tu Meifeng; Wang Huaquan; Xing Limin; Wang Jun; Fu Rong; Liu Hong; Wu Yuhong
Journal:  Int J Hematol       Date:  2011-01-14       Impact factor: 2.490

6.  CD8+HLA-DR+ T cells are increased in patients with severe aplastic anemia.

Authors:  Limin Xing; Chunyan Liu; Rong Fu; Huaquan Wang; Jun Wang; Xiao Liu; Le Feng; Lijuan Li; Hui Liu; Honglei Wang; Tian Zhang; Zonghong Shao
Journal:  Mol Med Rep       Date:  2014-06-18       Impact factor: 2.952

Review 7.  Tumor-necrosis-factor-related apoptosis-inducing ligand (TRAIL).

Authors:  Simone Fulda
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

8.  Interleukin-1beta and tumor necrosis factor (TNF)-alpha sensitize human thyroid epithelial cells to TNF-related apoptosis-inducing ligand-induced apoptosis through increases in procaspase-7 and bid, and the down-regulation of p44/42 mitogen-activated protein kinase activity.

Authors:  Emese Mezosi; Su He Wang; Saho Utsugi; Laszlo Bajnok; James D Bretz; Paul G Gauger; Norman W Thompson; James R Baker
Journal:  J Clin Endocrinol Metab       Date:  2004-01       Impact factor: 5.958

Review 9.  Regulation of the human TRAIL gene.

Authors:  Joshua E Allen; Wafik S El-Deiry
Journal:  Cancer Biol Ther       Date:  2012-08-15       Impact factor: 4.742

10.  Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression.

Authors:  K Song; Y Chen; R Göke; A Wilmen; C Seidel; A Göke; B Hilliard; Y Chen
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

View more
  1 in total

1.  Interferon Gamma and perforin positive T cells in acquired aplastic anemia: implication in therapeutic response.

Authors:  Vandana Sharma; Prabin Kumar; Rajiv Kumar; Sushmita Chakraborty; Manju Namdeo; Sudha Sazawal; Uma Kanga; Tulika Seth; Dipendra Kumar Mitra
Journal:  Clin Exp Immunol       Date:  2021-12-10       Impact factor: 5.732

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.